🔗 Share this article

A shadow market for unapproved weight-loss drugs is propelled by social media fitness personalities and vendors on communication apps, according to recent findings.

Experimental Drug Acquiring Traction Online

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are encouraged to contact these accounts directly for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust market exists on Telegram, where communities with numerous of participants share “before and after” images, injection guides and claims of rapid UK delivery. Sellers market the substance there before directing buyers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Experts Express Concerns

However, doctors and pharmacists have warned that the distribution of what remains an unapproved medication in the UK is worrisome and could result in users injecting products of unknown origin.

Some experts said the demand for retatrutide could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that must not be promoted or distributed for personal consumption under the British medical regulations.

Several content creators try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach pharmaceutical, advertising, and consumer regulations, risking penalties, prosecution or prison.

Platform Response and Material Elimination

According to TikTok, the platform has removed violative content and prohibited related hashtags and query recommendations. The company stated it was dedicated to maintaining the service safe and allocating resources in enhancing compliance measures.

Online Marketplace Operations

Investigations also found groups with up to nine thousand participants marketing the experimental drug using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately displays channels with thousands of users, filled with images of weight loss, glowing testimonials and step-by-step guides for preparing or administering at home.

Within minutes of joining one community, a vendor posted WhatsApp details, where most transactions take place. The vendor sent an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about body mass, health issues or previous experience.

Item Information and Pricing

Inside these groups, posts show dark colored parcels with postal service stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors usually sold at 160 pounds for 20mg. When asked how much time a pen should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Service Oversight and Security Actions

A representative for Telegram stated it actively monitored dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting materials they can’t verify. Although the science behind this drug is sound, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent price rises for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her staff has previously seen individuals injured by personal administration from unverified sources. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been evaluated or authorized by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may expose users to possibly significant health risks”.